Single-Dose, Crossover Study To Compare Bioavailability Of Two Formulations Under Fed And Fasted Conditions

Completed · Phase 1

Conditions studied: Healthy

In brief

To Compare The Bioavailability Of 40 Mg Doses Of Pf-00345439 Modified Formulation K Vs. Original Formulation X Under Fed And Fasting Conditions In Healthy Volunteers

Key facts

Study ID

NCT02059915

Run by

Pain Therapeutics

People needed

134

Starts

2014-04-01

Expected to finish

2014-07-01

Last updated by the study team

2016-04-04

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy male and/or female subjects between 18 and 55 years of age

You may not qualify if…

• Evidence or history of clinically significant disease.
• Positive urine drug test

Where it is running

• Pfizer Investigational Site — Saint Paul, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.